Ercalcidiol interferes with the normal action of the vitamin D receptor, potentially impacting pathways regulated by vitamin D such as calcium homeostasis and immune function. It targets human endogenous metabolite.
Molecular Weight
412.65
Molecular Formula
C28H44O2
Targets
Human endogenous metabolite
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
Ercalcidiol functions as a vitamin D receptor inhibitor, important in studies of bone metabolism and calcium regulation.
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.